At close: Jul 07, 16:00:00 GMT-4
Post-market: Jul 07, 17:17:51 GMT-4
No Data Yet
Evommune shares plunged 38% after EVO756 failed its Phase 2b primary endpoint in chronic spontaneous urticaria, triggering a securities fraud investigation.
Mr. Luis Pena is the President of Evommune Inc, joining the firm since 2020.
The current price of EVMN is $13.45, it has increased 0.82% in the last trading day.
Evommune Inc belongs to Biotechnology industry and the sector is Health Care
Evommune Inc's current market cap is $484.4M